Register Login

BIOAFFINITY TECHNOLOGIES, INC. (BIAFW)

(19% Negative) BIOAFFINITY TECHNOLOGIES, INC. (BIAFW) Announces Delay in test Trials for diameter identified by lung cancer screening Due to Patient Enrollment Issues, Regulatory Process, Manufacturing Considerations

Full text
Register to leave comments
  • News bot March 10, 2026, 12:45 p.m.

    📋 BIOAFFINITY TECHNOLOGIES, INC. (BIAFW) - Clinical Trial Update

    Filing Date: 2026-03-10

    Accepted: 2026-03-10 08:45:14

    Event Type: Clinical Trial Update

    Event Details:

    BIOAFFINITY TECHNOLOGIES, INC. (BIAFW) Announces Clinical Trial Update BIOAFFINITY TECHNOLOGIES, INC. (BIAFW) provided an update on its clinical development programs. Clinical Development Highlights:
    • Drug Program: test, support
    • Diseases/Conditions: diameter identified by lung cancer screening, CyPath® Lung
    • Clinical Stage: Clinical Study, clinical trial
    • Update Type: Trial Timeline Adjustment
    • Primary Factors: Patient Enrollment, Regulatory Process
    • Collaboration: CyPath® Lung

    💼 Business Developments:

    • Partnership: Not available
    • Acquisition
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: BIOAFFINITY TECHNOLOGIES, INC.
    • Ticker Symbol: BIAFW

Search

News categories